Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
biotech
clinical trials
fda
new york blog main
abbvie
access biotechnology
access industries
akcea therapeutics
alnylam pharmaceuticals
anemia
atlas ventures
blood diseases
blood disorders
brian macdonald
cancer
codiak biosciences
cutaneous t-cell lymphoma
disc medicine
drug development
drugs
elizabeta nemeth
european medicines agency
exosome
financing
harvard pilgrim health care
hereditary transthyretin amyloidosis
incubation
inotersen
institute for clinical and economic review
jazz pharmaceuticals
licensing
merganser biotech
national top stories
new york top stories
newco
What
cells
3
×
medicine
new
advance
alnylam
anemia
approves
based
begin
biosciences
bio’s
blood
body
brings
bubbles
carry
class
clinical
codiak
disc
drug
ema
employ
europe
exosome
exosomes
fda
follows
formed
fund
gene
harmful
having
health
hits
interference
ipo
iron
launches
lead
Language
unset
Current search:
boston
×
cells
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug